Fate Therapeutics
FATE
FATE
227 hedge funds and large institutions have $1.06B invested in Fate Therapeutics in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 97 increasing their positions, 59 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 43
57% less capital invested
Capital invested by funds: $2.45B → $1.06B (-$1.39B)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
227
Holding in Top 10
2
Calls
$998K
Puts
$916K
Top Buyers
| 1 | +$22.4M | |
| 2 | +$18.3M | |
| 3 | +$15.7M | |
| 4 |
Two Sigma Investments
New York
|
+$13.3M |
| 5 |
Renaissance Technologies
New York
|
+$12.8M |
Top Sellers
| 1 | -$75.1M | |
| 2 | -$29.4M | |
| 3 | -$28.6M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$26.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.7M |